Pig-to-human tissue transplants 'imminent'
Trials could begin in the US within two years – but British expert warns that safety fears remain
Jeremy Laurance is a writer on health issues. He is former health editor of The Independent and the i and has covered the specialism for more than 20 years. He thinks the harm medicine does is under-appreciated, the harm it prevents over-rated, and that cycling works better than most drugs. He was named Specialist Journalist of the Year in the 2011 British Press Awards.
Friday 21 October 2011
The world is on the cusp of a medical revolution which will see transplants of tissue from genetically engineered pigs to treat a range of human diseases, US scientists say today.
Click HERE to view graphic (103k jpg)
Human trials could begin within two to three years of tissue taken from specially bred pigs to help the millions of sufferers from diabetes, brain diseases and blindness.
But a British expert challenged their findings saying the safety issues were still "unresolved". The fear is that a retrovirus could jump from pigs to humans and trigger a new pandemic – HIV is thought to have started from a cross-species infection.
In a review of xenotransplantation – using animal tissue and organs to replace human ones – experts from the Thomas Starzl Transplantation Institute at the University of Pittsburgh say the technology has made "great strides".
During the mid-1990s, Imutran, a small biotechnology company in Cambridge, became the first in the world to transplant pigs' hearts into monkeys, demonstrating that cross-species transplantation was possible. However, immune system rejection problems proved more difficult than expected and safety fears dampened enthusiasm.
A decade on, attention has focused on the transplant of cells and tissues rather than organs – pancreatic islets for diabetics, brain cells for Parkinson's disease and corneas for the blind.
Problems remain, including loss of transplanted cells, blood clots and other rejection problems. New, genetically modified pigs will shortly become available which could overcome these issues and make human trials of transplanted tissue "imminent".
The US scientists discount safety fears saying retroviruses "do not pose a substantial risk".
That was challenged by Robin Weiss, professor of virology at University College, London, and an expert on retroviruses. He said yesterday: "I don't think the risk issues have been resolved. That doesn't mean clinical trials shouldn't go ahead but there would need to be very close monitoring of patients to ensure they were not picking something up from pigs."
elephant appealThe first 23 lots in our charity auction have now gone. But there are 22 more still up for grabs
musicPolice chief rejects rappers' claims that his work is as dangerous as law enforcement or military service
comedy'Fresh Meat' star sees off stiff competition from Alan Carr, David Mitchell, Graham Norton, Lee Mack and Sarah Millican to win top prize
Life & Style blogs
The 50 Best Christmas Gifts for Women
Foodini: the £835 machine that 'prints' food in your kitchen
Physicists discover 'clearest evidence yet' that the Universe is a hologram
In pictures: Christmas in London through the ages
Pirate Bay sets sail for Ascension Island after SX domain name seized by authorities
- 1 French café starts charging extra to rude customers
- 2 Italian court annuls prison sentence for elderly paedophile after 11-year-old victim tells investigators in Catanzaro that she loves him
- 3 Australia incest case: Deformed children found in remote farming community after generations of inbreeding
- 4 Physicists discover 'clearest evidence yet' that the Universe is a hologram
- 5 Fox News presenter tells viewers it is a 'fact' that both Jesus and Santa Claus are white
- < Previous
- Next >
£40000 - £50000 per annum + BONUS + BENEFITS: Harrington Starr: A leading prov...
£47999 - £58001 per annum + Benefits: Pro-Recruitment Group: A Top Tier practi...
£74000 - £92000 per annum: Pro-Recruitment Group: Financial Services Lawyer 2-...
attractive: Citifocus: Leading Asset Management house, wish to identify a temp...